Analyze Diet
Veterinary dermatology2017; 28(6); 629-e155; doi: 10.1111/vde.12471

Successful medical treatment of an Aspergillus terreus mycetoma of the nostril/lip in a 16-year-old Fjord pony gelding with pituitary pars intermedia dysfunction.

Abstract: Mycetoma is a chronic, proliferative lesion of cutaneous/subcutaneous tissue characterized by draining tracts and granules in the discharge caused by actinomycetes (actinomycetoma) or filamentous fungi (eumycotic mycetoma). Objective: This case report describes the unusual finding of a cutaneous mycetoma of the lateral wing of the right nostril in a gelding. Methods: A 16-year-old Fjord gelding with suspected pituitary pars intermedia dysfunction (PPID) was presented for evaluation of a nonpainful, firm and raised mass involving the lateral wing of the right nostril and the lip. Results: Cytological examination of the mass showed marked pyogranulomatous inflammation and histopathological examination revealed a fungal mycetoma. Fungal culture identified the causative organism as Aspergillus terreus, which is not known for its propensity to cause either dermal granulomas or mycetoma in domestic animals. Further investigation, including a TRH stimulation test, led to a diagnosis of PPID (Cushing's disease), which may have led to immunosuppression of the animal and increased susceptibility to infection. Conclusions: The horse was treated medically with pergolide for the PPID and oral potassium iodide for the fungal infection, with good therapeutic response and no relapse after five months. Surgical debridement or excision was not performed. To the best of the authors' knowledge, this is the first case report of a cutaneous mycetoma caused by A. terreus in a horse.
Publication Date: 2017-07-23 PubMed ID: 28736852DOI: 10.1111/vde.12471Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper recounts a unique case of a 16-year-old horse with a nonpainful tumor-like growth on its nostril, caused by a rare type of fungal infection. The horse was also diagnosed with an endocrine disorder, which may have made it more susceptible to the infection. The infection was successfully treated with medication and did not return after five months.

Objective and Overview

The research aims to report a rare case of cutaneous mycetoma in a 16-year-old gelding pony. The growth was caused by Aspergillus terreus, a fungus not typically known to cause such diseases in animals. The gelding was reportedly suspected of having Pituitary Pars Intermedia Dysfunction (PPID), which played a role in the case.

  • The gelding was afflicted by mycetoma, which is a condition characterized by chronic and proliferative lesions of the skin or subcutaneous tissue.
  • This condition is normally caused by the actinomycetes or filamentous fungi, hence the paper outlines an unusual case of the disease caused by the Aspergillus terreus fungus.

Methods and Results

The research adopted cytological and histopathological examinations to investigate the unusual growth on the pony’s nostril.

  • The cytological examination revealed a marked pyogranulomatous inflammation, or an inflamed mass composed of neutrophils, a type of white blood cell, in the mass.
  • A histopathological examination, which is a microscopic examination of tissue, confirmed that the mass was a fungal mycetoma.
  • The causative agent was identified as Aspergillus terreus, a fungal organism, via a fungal culture examination.
  • Further investigation with a TRH stimulation test confirmed the presence of PPID (commonly known as Cushing’s disease) in the pony. This condition may result in immune suppression, thereby increasing the animal’s susceptibility to fungal infections.

Conclusion

Despite the unusual nature of the infection and the complexity involved due to the presence of PPID, the treatment employed was successful.

  • The pony was medically treated with pergolide medication for the PPID and given oral potassium iodide to combat the fungal infection.
  • Notably, the treatment did not involve any surgical debridement or excision.
  • The gelding responded well to the therapy, with no recurrence of the fungal growth after five months.
  • The paper acknowledges this case as the first known instance of a cutaneous mycetoma caused by A. terreus in a horse to their knowledge.

Cite This Article

APA
Randleff-Rasmussen PK, Mosca M, Knoerr F, Pin D, Desjardins I. (2017). Successful medical treatment of an Aspergillus terreus mycetoma of the nostril/lip in a 16-year-old Fjord pony gelding with pituitary pars intermedia dysfunction. Vet Dermatol, 28(6), 629-e155. https://doi.org/10.1111/vde.12471

Publication

ISSN: 1365-3164
NlmUniqueID: 9426187
Country: England
Language: English
Volume: 28
Issue: 6
Pages: 629-e155

Researcher Affiliations

Randleff-Rasmussen, Pia K
  • VetAgro Sup, Veterinary Campus of Lyon, University of Lyon, 69280, Marcy l'Etoile, France.
Mosca, Marion
  • VetAgro Sup, Veterinary Campus of Lyon, University of Lyon, 69280, Marcy l'Etoile, France.
Knoerr, Frédéric
  • Cabinet Vétérinaire du Vallon, 465 route de la Merlanchonnière, 42740, St Paul en Jarez, France.
Pin, Didier
  • VetAgro Sup, Veterinary Campus of Lyon, University of Lyon, 69280, Marcy l'Etoile, France.
Desjardins, Isabelle
  • VetAgro Sup, Veterinary Campus of Lyon, University of Lyon, 69280, Marcy l'Etoile, France.

MeSH Terms

  • Animals
  • Antifungal Agents / therapeutic use
  • Aspergillosis / veterinary
  • Aspergillus
  • Dopamine Agonists / therapeutic use
  • Horse Diseases / microbiology
  • Horses
  • Lip Diseases / microbiology
  • Lip Diseases / veterinary
  • Male
  • Mycetoma / microbiology
  • Mycetoma / veterinary
  • Nose Diseases / microbiology
  • Nose Diseases / veterinary
  • Pergolide / therapeutic use
  • Pituitary Diseases / veterinary
  • Pituitary Gland, Intermediate
  • Potassium Iodide / therapeutic use

Citations

This article has been cited 0 times.